82_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 20_CD SUBSIDIARIES_NNS Details_NNS of_IN the_DT Groups_NNS principal_JJ subsidiaries_NNS ,_, including_VBG their_PRP$ names_NNS ,_, countries_NNS of_IN incorporation_NN and_CC percentage_NN proportion_NN of_IN ownership_NN are_VBP provided_VBN in_IN note_NN 47_CD ._.
21_CD INVESTMENTS_NNS IN_IN ASSOCIATES_NNPS Share_NN of_IN net_JJ assets_NNS Goodwill_NNP Total_NNP million_CD million_CD million_CD At_IN 1_CD January_NNP 2004_CD 157.1_CD 83.8_CD 240.9_CD Share_NN of_IN post_NN tax_NN earnings_NNS 34.0_CD 34.0_CD Dividends_NNP 4.3_CD 4.3_CD Businesses_NNS acquired_VBD 36.4_CD 5.7_CD 42.1_CD Transfer_NN from_IN other_JJ investments_NNS 14.4_CD 14.4_CD Businesses_NNS disposed_VBD 2.3_CD 2.3_CD Adjustments_NNS in_IN respect_NN of_IN prior_JJ year_NN investments_NNS 1.0_CD 1.0_CD Currency_NNP translation_NN differences_NNS 8.0_CD 0.6_CD 8.6_CD At_IN 1_CD January_NNP 2005_CD 243.3_CD 89.1_CD 332.4_CD Share_NN of_IN post_NN tax_NN earnings_NNS 45.3_CD 45.3_CD Dividends_NNS 16.1_CD 16.1_CD Businesses_NNS acquired_VBD 5.2_CD 12.9_CD 18.1_CD Part_NN disposal_NN of_IN subsidiary_NN undertaking_NN 13.8_CD 13.8_CD Investment_NN in_IN existing_VBG associate_JJ 10.0_CD 10.0_CD Conversion_NNP of_IN associate_NN to_TO subsidiary_NN 16.3_CD 16.3_CD Repayment_NN of_IN capital_NN 2.8_CD 2.8_CD Currency_NNP translation_NN differences_NNS 10.6_CD 0.5_CD 10.1_CD At_IN 31_CD December_NNP 2005_CD 293.0_CD 101.5_CD 394.5_CD Details_NNS of_IN the_DT Groups_NNS principal_JJ associates_NNS are_VBP provided_VBN in_IN note_NN 47_CD ._.
Included_VBN within_IN the_DT total_JJ carrying_NN value_NN of_IN investments_NNS in_IN associates_NNS was_VBD 157.8_CD million_CD 2004_CD 156.8_CD million_CD in_IN respect_NN of_IN listed_VBN companies_NNS ._.
The_DT market_NN value_NN of_IN the_DT holdings_NNS based_VBN on_IN the_DT closing_NN share_NN prices_NNS at_IN 31_CD December_NNP 2005_CD was_VBD 248.3_CD million_CD 2004_CD 231.2_CD million_CD ._.
The_DT part_NN disposal_NN of_IN subsidiary_NN undertaking_NN and_CC investment_NN in_IN existing_VBG associate_JJ relate_VBP to_TO the_DT disposal_NN of_IN 51_CD %_NN of_IN the_DT Groups_NNS interest_NN in_IN Alliance_NNP UniChem_NNP Farmacutica_NNP S._NNP A._NN and_CC the_DT Groups_NNS subsequent_JJ purchase_NN of_IN its_PRP$ share_NN of_IN new_JJ equity_NN issued_VBN by_IN the_DT company_NN ._.
The_DT conversion_NN of_IN associate_NN to_TO subsidiary_NN relates_VBZ to_TO the_DT Groups_NNS increase_NN in_IN its_PRP$ direct_JJ ownership_NN in_IN Alloga_NNP S._NNP A._NN from_IN 20_CD %_NN to_TO 100_CD %_NN ,_, with_IN the_DT exception_NN of_IN the_DT Swiss_JJ part_NN of_IN the_DT business_NN ._.
This_DT transaction_NN was_VBD part_NN of_IN the_DT Groups_NNS restructuring_NN of_IN its_PRP$ relationship_NN with_IN Galenica_NNP S._NNP A._NN in_IN which_WDT it_PRP holds_VBZ a_DT 25.5_CD %_NN interest_NN in_IN the_DT ordinary_JJ share_NN capital_NN ._.
One_CD of_IN the_DT Group_NNP associates_NNS ,_, Hedef_NNP Alliance_NNP Holding_NNP A._NNP S._NNP operated_VBD in_IN a_DT hyperinflationary_JJ environment_NN ._.
During_IN 2005_CD ,_, a_DT monetary_JJ loss_NN of_IN 4.0_CD million_CD 2004_CD 7.9_CD million_CD was_VBD recognized_VBN and_CC recorded_VBN within_IN share_NN of_IN post_NN tax_NN earnings_NNS ._.
The_DT aggregated_JJ assets_NNS and_CC liabilities_NNS reported_VBN by_IN these_DT associates_NNS were_VBD as_IN follows_VBZ :_: 2005_CD 2004_CD million_CD million_CD Total_JJ assets_NNS 2,334.7_CD 2,052.5_CD Total_JJ liabilities_NNS 1,518.6_CD 1,326.7_CD Net_JJ assets_NNS 816.1_CD 725.8_CD Group_NNP share_NN 293.0_CD 243.3_CD The_DT aggregated_JJ revenues_NNS reported_VBN by_IN these_DT associates_NNS were_VBD as_IN follows_VBZ :_: 2005_CD 2004_CD million_CD million_CD Total_JJ revenue_NN 5,450.7_CD 4,724.2_CD Group_NNP share_NN 1,965.3_CD 1,707.5_CD
